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Methods: The information of the patients who admitted to the tuberculosis care unit of our hospital since 2015 to 2017 were reviewed with clinical chart. Patients were divided into two groups, one is ILD group and the other is non-ILD group. Mortality and length of stay in ward were compared in the two groups. Fisher's exact test and Mann-Whitney test were used.
Results: 371 patients were enrolled and the percentage of the patients with ILD was 7.3% (27/371). The mortality of the ILD group and non-ILD group were 22.2% and 11.9%, respectively (P = 0.132). The length of stay in ward of the two groups were 67. AE 0.3 and 55. AE 1.9 days respectively (P = 0.480).
Conclusion:
Complication of ILD for the patients with pulmonary tuberculosis resulted in the trend of higher mortality and longer stay in ward, but they were not significant. Background and Aims: Tuberculosis is still a high burden problem in Indonesia. The problem increased by MDR case since we are in the top ten rank. The most important thing of MDR is diagnosis. The faster and more accurate the diagnosis of MDR TB, expected higher treatment rate. That's why we use rapid molecular test (GeneXpert MTB/RIF Assay) and DST test. The sensitivity and specificity of GeneXpert MTB/RIF assay for the diagnosis of MDR-TB was found to be comparable to gold standard, conventional DST. In this case we discussed about the difference result between culture and rapid molecular test.
Methods: A 35 year old previously treated female presented with cough more than 2 weeks, weight loss, loss of appetite, shortness of breath, night sweating and fatigue. Chest X-Ray showed opacity at the upper and mid-zone of right lung and cavity at the apex of the lung. From hospital examination, the smear showed 1+ and Gene Xpert MTB Assay showed MTB positive rifampicin susceptible. From research sputum specimen, it was 1+ smear and MTB positive rifampicin susceptible. Patient received DS-TB line 1 treatment. Three months later, Drug Sensitivity Test (DST) from hospital showed Rifampicin, Streptomycin and Isoniazid Resistance. Meanwhile, DST from research sputum showed Mycobacterium other Than TB (MoTT). Patient was diagnosed as MDR-TB and has got Short Term Regimen. Investigators confirm the diagnosis by GenoscholarTM test and it was found that the DNA was susceptible for Rifampicin and Isoniazid. Results: Data was collected from 62 patients .Domain scores were generally better in males, younger (<50 yr. old) patients, patients with higher incomes, single, college graduates, and patients with a shorter course of treatment.
The most affected was the physical health domain which assesses the impact of disease on the level of independence, activities of daily living, pain and discomfort, dependence on medicinal substance, lack of energy, sleep and rest, mobility and capacity to work on the other hand .
Followed closely by the psychological domain which assesses the impact of self-esteem, positive and negative feelings, bodily appearance and spirituality, then the social relationships domain which assesses social support, personal relationship and sexuality.
Environmental health domain was least affected.
Conclusion: MDR-TB affects quality of life both directly and indirectly. This study suggests to design an applicable, reliable and valid TB/MDR-TB-specific HRQL instrument, which can better address quality of life issues methodologically. This would further enable the health care professionals and management to devise relevant interventions to improve the quality of the patients, as well as the programme. Background and Aims: Hypersensitivity reaction to antituberculosis medications poses a great challenge. Its incidence ranges from 4-6% of cases (Siripassorn et al. 2018) . Normally second-line drugs would be given once reaction developed however, desensitization to the offending drug is an alternative strategy.
Methods:
We report three cases of hypersensitivity reaction to antituberculosis drug with successful desensitization. They had allergic skin rash while on fixed-dose combination or loose tablet. The culprit drug
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